Press release
Achieving Quality and Compliance Excellence in Pharmaceuticals - New Book Released
In todays contemporary pharmaceutical industry, the focus has slowly but surely shifted from the elusive research pipeline and latest blockbuster molecules to current processes, efficiencies and manufacturing systems. A path most often taken by manufacturers today in this direction includes improving their overall quality and compliance efforts. This results in a two-pronged approach of minimizing the litigation cost and concurrently improving the overall quality of the products and efficiencies in their processes and procedures. This book provides current thinking and approaches to achieving quality and compliance from top industry experts and is pioneering in bringing this wealth of information together in a single volume which will be of great use to the pharmaceutical industry. Compliance and quality issues have been comprehensively covered, from GMP requirements to deviation management, OOS and CAPA methodologies, QRM and QMS practical implementation, qualification and validation, records and documentation practices, latest GMP training techniques and performance metrics for compliance and detailed analysis of ICH guidelines for practical implementation.Over twenty top experts in their respective fields have come together from USA, Europe and Asia to fill the knowledge gap that was existing in this fields for some years.
This is a practical how-to book that emphasizes easy implementation of quality and compliance strategies that pharmaceutical manufacturers can directly benefit from.
"The changing regulatory environment encourages a risk-based and performance-governed compliance approach based on an agile quality framework. Such an approach is fundamental to maintaining competitiveness, irrespective of location and cost base. This book not only encourages and details the application of these modern quality paradigms in a single guide, it is also an aide and an encouragement for those in industry who wish to learn from the best, continually improve, embrace advancement of science and benchmark themselves. The high calibre of the authors and the diligence of the editor assure comprehensive, current and exceedingly high quality of the contents." - from the Foreword in the book by Siegfried Schmitt, PhD, Paraxel, UK
Hardbound 664 pages, ISBN 9788190646789, First Edition 2012
Editor: Madhu Raju Saghee (M.Sc.) is working in corporate quality department at Gland Pharma, in Hyderabad, India. In this position, he is responsible for implementing a robust quality system, ensuring regulatory compliance and involved in qualification and validation of sterile and aseptic manufacture for parenterals. Madhu is also a Director for Indian region for Pharmaceutical and Healthcare Sciences Society (PHSS).
More details from: http://businesshorizons.com/english/products/product-detail.asp?code=PHCOM50030&subject_id=2
Publishers of books devoted exclusively for the pharmaceutical and herbal medicine industry.
Business Horizons
G-59, Masjid Moth, GK-2
New Delhi-110048, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Achieving Quality and Compliance Excellence in Pharmaceuticals - New Book Released here
News-ID: 227948 • Views: …
More Releases from Business Horizons

PHARMA MANUFACTURING COVID-19 CHALLENGE
New Delhi, 19 June, 2020 - Business Horizons, pharmaceutical publishers, announces the launch of their latest publication titled Pharma Manufacturing Covid-19 Challenge. This is their latest offering in the field of pharmaceutical books, after the highly successful earlier book Pharmaceutical Facility Management.
In December 2019, China began noticing a disturbing trend of pneumonia like cases that were fast multiplying in the city of Wuhan, the sprawling capital of central China’s Hubei…

Pharmaceutical Facility Management – New Book Released
The new 2014 second edition of this bestselling book is bigger, better and takes the reader to the next level. Hardbound 424 pages, ISBN: 9788190646796
The new second edition of this bestselling book is bigger, better and takes the reader to the next level and future ready. While the earlier edition was all about smooth and troublefree working of a pharmaceutical facility, the new second edition strives to achieve excellence and…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…